Arecor to present on Investor Meet Company
CEO and CFO to present FY24 results on Investor Meet Company platform on 1 May 2025.
Select text to share a quote on X · sign in to keep highlights & notes in your AREC notes
Cambridge, UK, 24 April 2025: Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical company advancing today's therapies to enable healthier lives, today announces that Sarah Howell, Chief Executive Officer, and David Ellam, Chief Financial Officer, will be providing a live presentation of the Group's recently announced final results for the year ended 31 December 2024 via the Investor Meet Company platform on Thursday 1 May 2025 at 2pm BST.
To sign up to Investor Meet Company for free and to register for Arecor's presentation, please visit:
Investors who already follow Arecor on the Investor Meet Company platform will automatically be invited to the event.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.